Monitor SEC effectiveness of the F-1 registration statement, which would allow EIB to begin selling shares. Watch for any EIB sales that could create overhang on EVAX stock given the 38.45 million ordinary shares registered (8.5% of current outstanding). The company's cash burn rate and need for additional capital remain key concerns.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $2.75entry
- T+1 · 7d ago +4.00%α +4.37% · $2.86
- T+5 · 20h ago +0.73%α +2.42% · $2.77
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Evaxion filed Amendment No. 1 to its F-1 registration statement and a related 6-K press release on November 9, 2026, to register for resale up to 38,450,000 ordinary shares (769,000 ADSs) issuable upon exercise of warrants held by the European Investment Bank (EIB) under a July 2025 debt settlement agreement. The company is not selling securities or receiving proceeds from the resale; it received a EUR 3.5 million debt cancellation in exchange for the warrants and may receive up to approximately $1.5 million if the warrants are exercised. The filing is a routine procedural step to fulfill registration rights granted to EIB, not a new capital raise.
Key Financial Metrics
Key Facts
- Evaxion filed Amendment No. 1 to Form F-1 (File No. 333-291685) on November 9, 2026, registering up to 38,450,000 ordinary shares (769,000 ADSs) for resale by EIB.
- The shares are issuable upon exercise of warrants issued to EIB under a July 11, 2025 debt settlement agreement, which cancelled EUR 3.5 million of a EUR 7 million loan.
- Evaxion is not selling any securities and will not receive proceeds from the resale; it may receive up to DKK 9,612,500 (approx. $1.5 million) if warrants are exercised.
- The warrants have an exercise price of DKK 0.25 per ordinary share, expire in ten years, and were issued at an effective conversion price of $4.87 per ADS (89% premium to market at the time).
- As of September 30, 2026, Evaxion had 451,074,156 ordinary shares outstanding; full warrant exercise would bring total to 489,524,156 ordinary shares.
- The registration statement has not yet become effective; no sales can occur until it is declared effective by the SEC.
- Evaxion's cash and cash equivalents were $14.0 million as of June 30, 2026, down from $23.2 million at December 31, 2025.
- The company reported revenue of $7.5 million in FY2025 (up from $3.3 million in FY2024) and a net loss of $7.7 million.
Financial Impact
EUR 3.5 million debt cancellation already received; potential additional gross proceeds of up to DKK 9,612,500 (approx. $1.5 million) from warrant exercise. No new capital raised.
Risk Factors
- Potential overhang from EIB resale of up to 38.45 million ordinary shares (769,000 ADSs) once registration becomes effective.
- Company's cash position declining ($14.0M at June 30, 2026 vs. $23.2M at Dec 31, 2025) with ongoing operating losses.
- Registration statement not yet effective; timing of effectiveness uncertain.
- Warrant exercise is uncertain and contingent on EIB's decision; company may receive no additional proceeds.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 11 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (EVAX), Batch item 1 | 0001171843-26-007255 |
| Exhibit: exh_991.htm | 0001171843-26-007254 |
| Document: 0001171843-26-007255-index-headers.html | press-3398322 |
| Document: 0001171843-26-007255-index.html | 0001171843-26-007255 |
| Document: 0001171843-26-007255.txt | 0001171843-26-007255 |
| F-1/A Filing (EVAX), Batch item 6 | 0001171843-26-007254 |
| Exhibit: exh_231.htm | 0001171843-26-007255 |
| Document: 0001171843-26-007254-index-headers.html | 0001171843-26-007255 |
| Document: 0001171843-26-007254-index.html | 0001171843-26-007255 |
| Document: 0001171843-26-007254.txt | 0001171843-26-007255 |
| PRESS-RELEASE Data (Synthetic) | 0001171843-26-007255 |
Track record
50 reports on EVAX
7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
- Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
- Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Viewing Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
- Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
- Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
- Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
- Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
- Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
- Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers